Recipharm, a contract development and manufacturing organization, has invested EUR 3.7 million ($4.1 million) to expand its lyophilization capacity at its site in Masate, Italy. This investment is in addition to an ongoing EUR 32 million ($36 million) investment at the company's Wasserburg, Germany to increase capacity.

The Masate facility specializes in aseptic manufacturing and filling of parenterals as well as offering lyophilization capabilities in both vials and ampuls. The investment will introduce a new lyophilizer for vials, bringing the total number of machines from five to six and increasing the facility's capacity by approximately 20%.

Source: Recipharm